Filter
389
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
115
Language
Document type
No document type
196
Guidelines
72
Studies & Reports
46
Strategic & Response Plan
32
Manuals
24
Training Material
7
Fact sheets
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
23
Ghana
15
Uganda
15
India
14
Global
14
Western and Central Europe
13
Nigeria
12
Namibia
12
South Africa
11
Ethiopia
10
Eastern Europe
10
Nepal
9
Zambia
8
Rwanda
8
Sierra Leone
7
Tanzania
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Russia
3
Congo, Democratic Republic of
2
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Cameroon
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Burundi
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
49
Public Health
9
Pharmacy & Technologies
8
Capacity Building
6
Women & Child Health
6
Key Resources
6
Toolboxes
TB
47
Pharmacy
44
AMR
32
Malaria
31
HIV
22
COVID-19
21
NTDs
17
NCDs
5
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola & Marburg
1
Cholera
1
Polio
1
Specific Hazards
1
2.0 Rapid Response
1
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document.
...
Drugs & Therapy Perspectives vol.36 (2020) 6
Interim policy guidance
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y
...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...